Cargando…

Emerging diagnostic and therapeutic strategies for urothelial carcinoma

Detalles Bibliográficos
Autores principales:	Moschini, Marco, Sanchez-Salas, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954481/ https://www.ncbi.nlm.nih.gov/pubmed/33763242 http://dx.doi.org/10.1080/2090598X.2021.1876203

Ejemplares similares

The need to improve TURB: a diagnostic and therapeutic fundamental first step in the disease’s management
por: Moschini, Marco, et al.
Publicado: (2019)

Focal therapy for prostate cancer – index lesion treatment vs. hemiablation. A matter of definition
por: Stabile, Armando, et al.
Publicado: (2019)

Urothelial Carcinoma
por: Chow, Nan-Haw, et al.
Publicado: (2012)

Enhanced recovery after surgery (ERAS) in radical cystectomy patients: from consensus to evidences
por: Moschini, Marco, et al.
Publicado: (2019)

Current and Emerging Strategies to Treat Urothelial Carcinoma
por: Rani, Berkha, et al.
Publicado: (2023)

Lymphadenectomy for Upper Tract Urothelial Carcinoma: A Systematic Review
por: Duquesne, Igor, et al.
Publicado: (2019)

Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma
por: Mollica, Veronica, et al.
Publicado: (2020)

Therapeutic strategies for asymptomatic upper urinary tract urothelial carcinoma
por: Lin, Deng, et al.
Publicado: (2022)

Diagnostic or Therapeutic Strategies for Pregnancy Complications
por: Couture, Camille, et al.
Publicado: (2022)

Management of Upper Tract Urothelial Carcinoma
por: Smith, Norm D.
Publicado: (2009)

Metastasis: Genetics, Mechanism, and Diagnostic and Therapeutic Strategies
por: Gunduz, Mehmet, et al.
Publicado: (2012)

Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine?
por: Audisio, Marco, et al.
Publicado: (2022)

Neoadjuvant Immunotherapy: The Next Gold Standard Before Radical Surgery for Urothelial Cancer
por: Raggi, Daniele, et al.
Publicado: (2021)

Does perioperative systemic therapy represent the optimal therapeutic paradigm in organ-confined, muscle-invasive urothelial carcinoma?
por: Scafuri, Luca, et al.
Publicado: (2021)

Promoting Illiteracy in Epigenetics: An Emerging Therapeutic Strategy
por: Wigle, Tim J
Publicado: (2011)

Usefulness of pT1 substaging in papillary urothelial bladder carcinoma
por: Patriarca, Carlo, et al.
Publicado: (2016)

Chronic Kidney Disease and Upper Tract Urothelial Carcinomas
por: Wang, Li-Jen, et al.
Publicado: (2014)

Building bridges in urothelial carcinoma to face common challenges
por: Mathieu, Romain, et al.
Publicado: (2016)

Accelerating Early Access to Immunotherapies for Advanced Urothelial Carcinoma
por: Ning, Yang‐Min, et al.
Publicado: (2017)

Are all metachronous multifocal urothelial carcinoma created equal?
por: Reis, Leonardo O.
Publicado: (2018)

Laparoscopic nephroureterectomy for upper tract urothelial carcinoma – Update
por: Lin, Victor C., et al.
Publicado: (2016)

Trimodality therapy in variant urothelial carcinoma: choose wisely
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2017)

The impact of perioperative blood transfusion on survival outcomes in radical cystectomy patients
por: Moschini, Marco
Publicado: (2017)

From Basic Science to Clinical Research to Develop New Solutions to Improve Diagnoses and Treatment of Bladder Cancer Patients
por: Moschini, Marco
Publicado: (2020)

Molecular Characterization of Upper Tract Urothelial Carcinoma for Precision Therapeutics and Non-invasive Diagnostics
por: Sugawara, Emiko, et al.
Publicado: (2022)

Molecular Research on Emerging Viruses: Evolution, Diagnostics, Pathogenesis, and Therapeutics
por: Lau, Susanna K. P.
Publicado: (2018)

Novel immunotherapy approaches for metastatic urothelial and renal cell carcinoma
por: Shao, Zhiying, et al.
Publicado: (2016)

Clinical registries in upper tract urothelial carcinoma: commitment to collaboration
por: Zeng, Jiping, et al.
Publicado: (2023)

Elucidation of Novel Molecular Targets for Therapeutic Strategies in Urothelial Carcinoma: A Literature Review
por: Nelson, Blessie Elizabeth, et al.
Publicado: (2021)

Durvalumab for the management of urothelial carcinoma: a short review on the emerging data and therapeutic potential
por: Baldini, Capucine, et al.
Publicado: (2019)

Oncological outcomes of laparoscopic versus open nephroureterectomy for the treatment of upper tract urothelial carcinoma: an updated meta-analysis
por: Piszczek, Radosław, et al.
Publicado: (2021)

Emerging Strategies to Improve the Design and Manufacturing of Biocompatible Therapeutic Materials
por: Martínez, Guillermo, et al.
Publicado: (2023)

Management of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: a literature review with emphasis on the role of surgery
por: Abufaraj, Mohammad, et al.
Publicado: (2016)

Toward clinical understanding of aristolochic acid upper-tract urothelial carcinoma
por: Boot, Arnoud, et al.
Publicado: (2020)

Practice change in the management of metastatic urothelial carcinoma after ASCO 2020
por: Gajate, Pablo, et al.
Publicado: (2020)

Diagnostic and Therapeutic Challenges of Rare Urogenital Cancers: Urothelial Carcinoma of the Renal Pelvis, Ureters and Urethra
por: Cassell, Ayun, et al.
Publicado: (2021)

Treatment Strategy for Dialysis Patient with Urothelial Carcinoma
por: Huang, Yun-Ching, et al.
Publicado: (2021)

Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma
por: Miyake, Makito, et al.
Publicado: (2018)

Emerging biomarkers in urothelial carcinoma: Challenges and opportunities
por: Andreatos, Nikolaos, et al.
Publicado: (2020)

Lenvatinib applicability in the therapeutic strategy of patients with hepatocellular carcinoma
por: Merle, Philippe
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ka0q04q0i29i9ktu8ddh9tdaju